Here, we demonstrate a loss of ATRX protein expression caused by severe loss-of-function ATRX gene alterations in almost a fifth of highly APTs, with a higher prevalence in PC than in APT, and in corticotroph tumors than in other lineage subtypes. This evidence concerns the gene ATRX and pachyonychia congenita.